Loading
Old version — revision 1
This is a fixed snapshot of Compression of morbidity, saved by Import as part of the initial corpus import. It is not edited and it is not updated; the article may have changed since.
Edit summary: Initial import of content/compression-of-morbidity.md — the filesystem corpus, unchanged. Not an edit.
The hypothesis that chronic illness can be postponed into a shorter interval before death, so that added years of life are healthy ones.
Compression of morbidity is the hypothesis that the age at which chronic illness and disability begin can be pushed back faster than the age of death, shortening the period of poor health at the end of life. It was set out by the Stanford physician James F. Fries in 1980 and has shaped how health systems and gerontologists think about the value of longer life ever since.1 Whether it has actually occurred in any national population remains disputed.
Fries argued from two premises. The first was that human lifespan has a natural ceiling — he took roughly 85 years as the average biological limit — so that the survival curve would become increasingly rectangular as premature death was eliminated, with most people dying in a narrow band near that age. The second was that the onset of chronic disease is more modifiable than the age of death, being driven substantially by behavior: smoking, inactivity, diet, and injury.
If both held, then improving those behaviors would push illness onset rightward while the death age stayed roughly fixed, squeezing morbidity into a shorter terminal interval. The clinical picture Fries described is of a person who remains functional into their eighties and then declines rapidly over months.
The first premise has not held. Maximum lifespan shows no sign of the fixed ceiling Fries assumed, and mean life expectancy in the longest-lived countries has passed 85 for women. This does not by itself refute the hypothesis; it removes the mechanism Fries relied on to keep the death age still while the onset age moved.
| Dimension | Compression | Expansion | Dynamic equilibrium |
|---|---|---|---|
| Associated with | Fries, 1980 | Gruenberg, 1977 | Manton, 1982 |
| Lifespan assumption | Fixed ceiling near 85 | None required | None required |
| Years lived with disease | Fall | Rise | Rise |
| Severity of that disease | Unchanged | Unchanged or worse | Falls |
| Net effect on function | Better | Worse | Roughly neutral |
| Care-cost implication | Lower lifetime cost | Higher lifetime cost | Shifted, not reduced |
The expansion thesis predates Fries. Ernest Gruenberg's "failures of success" argument held that medicine had become better at preventing death from chronic disease than at preventing the disease itself, so survival gains would accumulate as years lived in illness.2 Kenneth Manton's dynamic-equilibrium model split the difference: prevalence of chronic conditions rises because people survive with them, but average severity falls because progression slows, leaving aggregate function roughly stable.
These are not merely rival predictions. They imply different things about what medicine is doing. Compression implies prevention is working; expansion implies rescue is working and prevention is not.
The empirical record is mixed and depends heavily on which outcome is measured.
Measures of disability — difficulty with activities of daily living, institutionalization, mobility limitation — improved in the United States and several European countries through the 1980s and 1990s. Analyses of the US National Long Term Care Survey found sustained declines in chronic disability among older adults over that period, consistent with compression.
Measures of disease moved the other way. Studies tracking years of life lived with diagnosed chronic conditions have generally found expansion: as mortality from cardiovascular disease fell, the number of years spent living with cardiovascular disease rose. Crimmins and Beltrán-Sánchez examined both types of outcome in US data and concluded that the period had produced expansion of morbidity rather than compression, with gains in life expectancy accompanied by more years with disease and, on some measures, more years with functional loss.3
The disability gains also stalled. Rising obesity and diabetes prevalence in cohorts entering old age after 2000 halted and in places reversed the earlier improvement, and self-reported pain and mobility limitation in middle-aged cohorts have worsened in several high-income countries. Whether the widespread treatment of obesity with GLP-1 receptor agonists changes that trajectory is not yet answerable from population data.
Where compression does appear cleanly is in selected, self-selected groups. A long-running comparison of members of a runners' club with community controls found both lower mortality and a delay in the onset of disability of more than a decade, with disability curves that diverged rather than converging.4 It remains the strongest single piece of evidence that sustained physical activity compresses rather than merely postpones. Cohort studies of religious communities with low rates of smoking and drinking, including the Californian Seventh-day Adventists later folded into the Blue Zones literature, show similar patterns. These groups are not randomly assigned, so the effect is an upper bound on what behavior could achieve, not an estimate of it.
The disagreement in one lineCompression advocates point to declining disability rates in the late twentieth century; critics point out that those declines coincided with rising disease prevalence and have since stopped, and that the runners and Adventists who show the clearest compression differ from the general population in ways no policy can replicate.
Four measurement problems recur.
Diagnostic thresholds move. Hypertension, diabetes and chronic kidney disease have all been redefined downward over the period in question, converting healthy people into diseased ones by definition and mechanically producing "expansion".
Self-report drifts. Rising awareness and screening increase reported morbidity independent of any change in underlying health.
Disability depends on environment. Better housing, mobility aids and workplace accommodation reduce measured disability without changing the underlying impairment, so the same body can score as disabled in one decade and not the next.
And period-versus-cohort confusion is endemic. Most published claims compare cross-sections of different birth cohorts at the same age, which conflates aging effects with cohort effects such as childhood nutrition and smoking history.
Which scenario obtains determines the fiscal arithmetic of population aging. Under compression, longer lives are cheaper per person because the expensive interval of dependency stays short. Under expansion, each added year of life expectancy carries an added year of care costs, and long-term care rather than acute medicine becomes the binding constraint. Under dynamic equilibrium, costs shift from hospitals to community care without falling. The distinction also reframes the demographic objection discussed under Overpopulation and life extension: a population living longer in good function is not the same burden as one living longer in dependency, and the two are routinely conflated.
The scenarios carry ethical weight as well. A long terminal interval of dependency is the situation that assisted-dying law was written for, and expansion of morbidity enlarges the population facing it — a point taken up in Right to die and the duty to live. Whether the therapies that might compress morbidity reach the people whose morbidity is longest is a separate question, treated under Access and inequality; national statistics agencies that publish both figures generally find a wider gap in healthy life expectancy between the most and least deprived areas than in life expectancy itself.
This is the pivot on which the The longevity dividend argument turns. The economic case for investing in aging biology assumes compression: that delaying the underlying processes of aging delays disease onset across the board rather than extending survival with disease. The Geroscience hypothesis makes the same assumption explicit, and it is why geroscience trials favor composite endpoints counting multiple age-related conditions rather than mortality alone, the design Nir Barzilai built into the proposed TAME trial. Interventions such as Senolytics and Rapamycin are evaluated in animals on precisely this criterion — whether function is preserved, not merely whether survival is longer.
The counterexample sits in the animal literature: some life-extending manipulations lengthen the frail interval rather than shortening it, an outcome discussed under Healthspan. If human interventions behaved that way, life extension would deliver expansion by design.
Compression remains a policy target more than an observed fact. The strongest version — that morbidity can be squeezed against a fixed wall of natural death — depends on a premise that demographic data have not supported. The weaker and more useful version, that the proportion of life spent in poor health can be reduced, is testable and has not yet been achieved at population scale anywhere.
Whether it becomes achievable depends on something Fries did not consider: whether the onset of multiple age-related diseases shares an upstream driver that can be shifted at once. If it does, compression follows more or less automatically. If chronic diseases are largely independent, postponing them one at a time will keep producing what the record so far shows, which is longer lives containing more illness. Settling that question requires measures the field does not yet have and trials of a length nobody has yet funded.
paperFries, J.F. "Aging, Natural Death, and the Compression of Morbidity." New England Journal of Medicine, 1980. ↩
paperGruenberg, E.M. "The Failures of Success." Milbank Memorial Fund Quarterly, 1977. ↩
paperCrimmins, E.M. and Beltrán-Sánchez, H. "Mortality and Morbidity Trends: Is There Compression of Morbidity?" The Journals of Gerontology: Series B, 2011. ↩
paperChakravarty, E.F., Hubert, H.B., Lingala, V.B. and Fries, J.F. "Reduced Disability and Mortality Among Aging Runners: A 21-Year Longitudinal Study." Archives of Internal Medicine, 2008.↩Fries, who proposed the hypothesis, is an author, and the runners were recruited from a running club rather than randomized.